Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Mar;79(3):346–352. doi: 10.1111/j.1365-2249.1990.tb08094.x

Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis.

M Ferrarini 1, V Steen 1, T A Medsger Jr 1, T L Whiteside 1
PMCID: PMC1534953  PMID: 1969335

Abstract

Activated T lymphocytes often accumulate in the lower dermis of patients with systemic sclerosis (scleroderma) and may play a role in the development of dermal fibrosis. We propagated and cloned these cells directly from skin biopsies in four of eight cases of early, untreated systemic sclerosis with diffuse scleroderma. The cloning frequency estimates were f = 0.20 and f = 0.48 for T cells derived from the skin of two patients versus f = 0.68 and f = 0.96 for autologous blood T lymphocytes. All but one of 24 skin-derived scleroderma clones were CD4+. Clonal analyses performed with CD4+ clones from patients and normal controls showed that all but one skin-derived clones synthesized either interferon-gamma (60%), glycosaminoglycan-stimulatory factor (26%) or both (9%) when induced in vitro by a mitogen, concanavalin A, but not by autologous dermal fibroblasts. In contrast, blood-derived clones had a different functional phenotype. All skin-derived clones produced tumour necrosis factor-alpha. Our results demonstrate that T lymphocytes obtained from the skin of patients with systemic sclerosis synthesized cytokines which could modulate functions of human dermal fibroblasts.

Full text

PDF
346

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bashey R. I., Perlish S., Nochumson S., Stephens R. E., Fleischmajer R. Connective tissue synthesis by cultured scleroderma fibroblasts. II. Incorporation of 3h-glucosamine and synthesis of glycosaminoglycans. Arthritis Rheum. 1977 Apr;20(3):879–885. doi: 10.1002/art.1780200318. [DOI] [PubMed] [Google Scholar]
  2. Buckingham R. B., Prince R. K., Rodnan G. P., Taylor F. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma). J Lab Clin Med. 1978 Jul;92(1):5–21. [PubMed] [Google Scholar]
  3. Chen K., Demetris A. J., VanThiel D. H., Whiteside T. L. Double immunoenzyme staining method for analysis of tissue and blood lymphocyte subsets with monoclonal antibodies. Lab Invest. 1987 Jan;56(1):114–119. [PubMed] [Google Scholar]
  4. Jimenez S. A., McArthur W., Rosenbloom J. Inhibition of collagen synthesis by mononuclear cell supernates. J Exp Med. 1979 Dec 1;150(6):1421–1431. doi: 10.1084/jem.150.6.1421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Londei M., Bottazzo G. F., Feldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science. 1985 Apr 5;228(4695):85–89. doi: 10.1126/science.3871967. [DOI] [PubMed] [Google Scholar]
  6. Mayer T. G., Fuller A. A., Fuller T. C., Lazarovits A. I., Boyle L. A., Kurnick J. T. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. J Immunol. 1985 Jan;134(1):258–264. [PubMed] [Google Scholar]
  7. Miescher S., Whiteside T. L., Moretta L., von Fliedner V. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors. J Immunol. 1987 Jun 1;138(11):4004–4011. [PubMed] [Google Scholar]
  8. Moreau J. F., Bonneville M., Peyrat M. A., Godard A., Jacques Y., Desgranges C., Soulillou J. P. T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest. 1986 Oct;78(4):874–879. doi: 10.1172/JCI112674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Moretta A., Pantaleo G., Moretta L., Cerottini J. C., Mingari M. C. Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med. 1983 Feb 1;157(2):743–754. doi: 10.1084/jem.157.2.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Männel D. N., Moore R. N., Mergenhagen S. E. Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun. 1980 Nov;30(2):523–530. doi: 10.1128/iai.30.2.523-530.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pearson M. E., Huff J. C., Giorno R. C., Panicheewa S., Claman H. N., Steigerwald J. C. Immunologic dysfunction in scleroderma: evidence for increased mast cell releasability and HLA-DR positivity in the dermis. Arthritis Rheum. 1988 May;31(5):672–677. doi: 10.1002/art.1780310514. [DOI] [PubMed] [Google Scholar]
  12. Pober J. S., Collins T., Gimbrone M. A., Jr, Cotran R. S., Gitlin J. D., Fiers W., Clayberger C., Krensky A. M., Burakoff S. J., Reiss C. S. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature. 1983 Oct 20;305(5936):726–729. doi: 10.1038/305726a0. [DOI] [PubMed] [Google Scholar]
  13. Rosenbloom J., Feldman G., Freundlich B., Jimenez S. A. Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels. Arthritis Rheum. 1986 Jul;29(7):851–856. doi: 10.1002/art.1780290706. [DOI] [PubMed] [Google Scholar]
  14. Roumm A. D., Whiteside T. L., Medsger T. A., Jr, Rodnan G. P. Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum. 1984 Jun;27(6):645–653. doi: 10.1002/art.1780270607. [DOI] [PubMed] [Google Scholar]
  15. Saxon A., Feldhaus J., Robins R. A. Single step separation of human T and B cells using AET treated srbc rosettes. J Immunol Methods. 1976;12(3-4):285–288. doi: 10.1016/0022-1759(76)90050-8. [DOI] [PubMed] [Google Scholar]
  16. Schmidt J. A., Mizel S. B., Cohen D., Green I. Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol. 1982 May;128(5):2177–2182. [PubMed] [Google Scholar]
  17. Steffen M., Ottmann O. G., Moore M. A. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. J Immunol. 1988 Apr 15;140(8):2621–2624. [PubMed] [Google Scholar]
  18. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol. 1981 Apr;126(4):1614–1619. [PubMed] [Google Scholar]
  19. Tsao M., Ferrarini M., Evans C., Ambro A., Whiteside T. L. Purification of a glycosaminoglycan-stimulatory lymphokine from supernatants of in vitro-activated human mononuclear cells. Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 1):122–131. doi: 10.1016/0090-1229(89)90227-4. [DOI] [PubMed] [Google Scholar]
  20. Tsao M., Zeevi A., Whiteside T. L. Production of a glycosaminoglycan stimulatory factor by cloned human T lymphocytes activated in vitro. Arthritis Rheum. 1986 Sep;29(9):1071–1077. doi: 10.1002/art.1780290903. [DOI] [PubMed] [Google Scholar]
  21. Wahl S. M., Wahl L. M., McCarthy J. B. Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol. 1978 Sep;121(3):942–946. [PubMed] [Google Scholar]
  22. Whiteside T. L., Ferrarini M., Hebda P., Buckingham R. B. Heterogeneous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissues. Arthritis Rheum. 1988 Oct;31(10):1221–1229. doi: 10.1002/art.1780311002. [DOI] [PubMed] [Google Scholar]
  23. Whiteside T. L., Worrall J. G., Prince R. K., Buckingham R. B., Rodnan G. P. Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients. Arthritis Rheum. 1985 Feb;28(2):188–197. doi: 10.1002/art.1780280214. [DOI] [PubMed] [Google Scholar]
  24. Wing E. J., Magee D. M., Whiteside T. L., Kaplan S. S., Shadduck R. K. Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients. Blood. 1989 Feb 15;73(3):643–646. [PubMed] [Google Scholar]
  25. Yaron I., Meyer F. A., Dayer J. M., Yaron M. Human recombinant interleukin-1 beta stimulates glycosaminoglycan production in human synovial fibroblast cultures. Arthritis Rheum. 1987 Apr;30(4):424–430. doi: 10.1002/art.1780300410. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES